CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 136 filers reported holding CASTLE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,059 | +88.1% | 1,010 | +52.8% | 0.00% | – |
| Q2 2023 | $9,068 | -72.0% | 661 | -53.6% | 0.00% | – |
| Q1 2023 | $32,400 | +77.8% | 1,426 | +84.2% | 0.00% | – |
| Q4 2022 | $18,220 | -8.9% | 774 | -0.9% | 0.00% | – |
| Q3 2022 | $20,000 | +66.7% | 781 | +40.2% | 0.00% | – |
| Q2 2022 | $12,000 | -40.0% | 557 | +23.5% | 0.00% | – |
| Q1 2022 | $20,000 | – | 451 | +22450.0% | 0.00% | – |
| Q3 2021 | $0 | – | 2 | -50.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 4 | -100.0% | 0.00% | -100.0% |
| Q1 2021 | $22,951,000 | -41.4% | 335,245 | -42.5% | 0.00% | -33.3% |
| Q4 2020 | $39,146,000 | +82.9% | 582,951 | +40.2% | 0.00% | +50.0% |
| Q3 2020 | $21,399,000 | +87.1% | 415,924 | +37.1% | 0.00% | +100.0% |
| Q2 2020 | $11,438,000 | – | 303,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |